This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
April 04, 2024
Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2024
April 04, 2024
Ariceum Therapeutics to present new radioligand therapy data at American Association for Cancer Research (AACR) Annual Meeting 2024
April 04, 2024
Oncopeptides releases first quarter 2024 sales
April 03, 2024
Q4 2023 Annual General Market Overview
April 03, 2024
Carisma Therapeutics to Present at Upcoming Conferences
April 03, 2024
Q3 2023 General Market Overview
April 02, 2024
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
April 01, 2024
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
Carisma Therapeutics Announces Changes to its Board of Directors
March 28, 2024
Vicore Announces Presentations at the 2024 American Thoracic Society International Conference